Standard Biotools (LAB) Total Debt (2021 - 2024)
Historic Total Debt for Standard Biotools (LAB) over the last 7 years, with Q3 2024 value amounting to $54.9 million.
- Standard Biotools' Total Debt rose 47111.8% to $54.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $54.9 million, marking a year-over-year increase of 47111.8%. This contributed to the annual value of $57.9 million for FY2023, which is 46382.21% up from last year.
- As of Q3 2024, Standard Biotools' Total Debt stood at $54.9 million, which was up 47111.8% from $54.8 million recorded in Q2 2024.
- Over the past 5 years, Standard Biotools' Total Debt peaked at $57.9 million during Q4 2023, and registered a low of $9.6 million during Q3 2023.
- Its 4-year average for Total Debt is $24.6 million, with a median of $10.3 million in 2023.
- In the last 5 years, Standard Biotools' Total Debt crashed by 3914.25% in 2022 and then soared by 47111.8% in 2024.
- Over the past 4 years, Standard Biotools' Total Debt (Quarter) stood at $16.9 million in 2021, then plummeted by 39.14% to $10.3 million in 2022, then surged by 463.82% to $57.9 million in 2023, then decreased by 5.23% to $54.9 million in 2024.
- Its Total Debt was $54.9 million in Q3 2024, compared to $54.8 million in Q2 2024 and $54.7 million in Q1 2024.